Saturday, April 16, 2022

mRNA vaccine for Epstein-Barr Virus enters Phase I trial.


 mRNA vaccine for Epstein-Barr Virus enters Phase I trial.

Visit: https://infectious.pencis.com/
Contact us: infectious@pencis.com

#infectiousdiseases #bacteriology #virology #microbiology #medicine #zikavirus #bacteria #epidemiology #immunology #diphtheria #vaccin #tuberculosis #treatment #infection #virus
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

"COVID-19 Impact on Seasonal Outbreak Detection: SARIMAX-LSTM Hybrid Model Explained #InfectiousDiseases #COVID19Research #Pencis"

INTRODUCTION Seasonal infectious diseases have long posed significant public health challenges in the Republic of Korea. Influenza, noroviru...